PHARMACOLOGY OF ANTIPLATELET DRUGS AND CLINICAL TRIALS ON THROMBOSIS PREVENTION: A DIFFICULT LINK
- 30 October 1982
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 320 (8305), 974-977
- https://doi.org/10.1016/s0140-6736(82)90168-4
Abstract
No abstract availableThis publication has 48 references indexed in Scilit:
- Aspirin and Thromboembolism — A Possible DilemmaNew England Journal of Medicine, 1977
- Prostacyclin-like activity in rat vascular tissues. fast, long-lasting inhibition by treatment with lysine acetylsalicylateProstaglandins, 1977
- Acetylation of prostaglandin synthase by aspirin.Proceedings of the National Academy of Sciences, 1975
- Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.Proceedings of the National Academy of Sciences, 1975
- Duration of inhibition of platelet prostaglandin formation and aggregation by ingested aspirin or indomethacinProstaglandins, 1973
- Aspirin Selectively Inhibits Prostaglandin Production in Human PlateletsNature New Biology, 1971
- THE EFFECT OF ACETYLSALICYLIC ACID ON PLATELET FUNCTIONThe Journal of Experimental Medicine, 1968
- The effect of salicylates on the hemostatic properties of platelets in manJCI Insight, 1968
- EFFECTS OF SALICYLATES ON HUMAN PLATELETSThe Lancet, 1968
- Inhibition of Adenosine Diphosphate-Induced Secondary Aggregation and Other Platelet Functions by Acetylsalicylic Acid IngestionExperimental Biology and Medicine, 1968